Our study found no significant association between AR expression with either OS or bsPFS, which is not surprising given that our cohort consisted of multiple different breast cancer subtypes, which inherently portend different prognoses; the number of patients within each subtype was too small to draw meaningful conclusions. The gene discussed is AR; the disease is breast cancer.